John A. Barrett
Nessuna posizione attualmente
Storia della carriera di John A. Barrett
Precedenti posizioni note di John A. Barrett
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Direttore/Membro del Consiglio | - | 10/03/2005 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | 01/01/2000 | 01/01/2003 |
| ALAUNOS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
| PHIO PHARMACEUTICALS CORP. | Corporate Officer/Principal | 22/04/2019 | - |
| Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Direttore Tecnico/Scientifico/R&S | 01/01/1993 | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/08/2005 | - |
Formazione di John A. Barrett
| St. John's University | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Distribution Services |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Aziende private | 4 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Rorer Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- John A. Barrett
- Esperienza
